Viridian Therapeutics, Inc. (LON: 0K1R)

Viridian Therapeutics Revenue

Viridian Therapeutics had revenue of $86.00K USD in the quarter ending September 30, 2024, with 19.44% growth. This brings the company's revenue in the last twelve months to $302.00K, down -12.97% year-over-year. In the year 2023, Viridian Therapeutics had annual revenue of $314.00K, down -82.28%.

• Revenue (ttm): $302.00K
• Revenue Growth: -12.97%
• P/S Ratio: n/a
• Revenue / Employee: $3.21K
• Employees: 94
• Market Cap: 1.18B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	314.00K	-1.46M	-82.28%
Dec 31, 2022	1.77M	-1.19M	-40.20%
Dec 31, 2021	2.96M	1.91M	182.19%
Dec 31, 2020	1.05M	-3.41M	-76.46%
Dec 31, 2019	4.46M	-3.92M	-46.80%